Recruiting Geographic Atrophy Studies in University Park
About Geographic Atrophy Clinical Trials in University Park
Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.
There are currently 1 geographic atrophy clinical trials recruiting participants in University Park, PA. These studies are seeking a combined 144 participants. Research is being sponsored by Penn State University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Geographic Atrophy Clinical Trials in University Park — FAQ
Are there geographic atrophy clinical trials in University Park?
Yes, there are 1 geographic atrophy clinical trials currently recruiting in University Park, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in University Park?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the University Park research site will contact you about next steps.
Are clinical trials in University Park free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many University Park studies also compensate for your time and travel.
What geographic atrophy treatments are being tested?
The 1 active trials in University Park are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.
Data updated July 13, 2026 from ClinicalTrials.gov